Associate Professor of Medicine, University Pennsylvania
Infectious Disease
Dr. Neil O. Fishman, MD
Dr. Neil O. Fishman is an expert in the field of Infectious Disease. He graduated from Temple University School of Medicine. He over the years received 2 awards: "Regional Top Doctor" and "Super Doctor". Neil O. Fishman, MD is a published doctor as well. He has 98 publications published. The latest was: Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus. Doctor Neil O. Fishman, MD is registered with Medicare.
Publications
- Risk Factors for gyrA and parC Mutations in Pseudomonas aeruginosa.
- Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship.
- Usability and impact of a computerized clinical decision support intervention designed to reduce urinary catheter utilization and catheter-associated urinary tract inf...
- A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates.
- Antimicrobial Stewardship Interventions: Thinking Inside and Outside the Box.
- Reply to Simon, Shah et al, and Hartzema and Chen.
- The Effect of a Hospital-Wide Urine Culture Screening Intervention on the Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella Species.
- Impact of Antibiotic Use during Hospitalization on the Development of Gastrointestinal Colonization with Escherichia coli with Reduced Fluoroquinolone Susceptibility.
- The Mortality Review Committee: a novel and scalable approach to reducing inpatient mortality.
- Preventable mortality: does the perspective matter when determining preventability?
- Public reporting of hospital-acquired infections is not associated with improved processes or outcomes.
- Variations in identification of healthcare-associated infections.
- Risk Factors for Gastrointestinal Tract Colonization with Extended-Spectrum ò-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Species in Hospitalized Patie...
- Effectiveness of Interventions in Reducing Antibiotic Use for Upper Respiratory Infections in Ambulatory Care Practices.
- The surgery clerkship: an opportunity for preclinical credentialing in urinary catheterization.
- Prior Vancomycin Use Is a Risk Factor for Reduced Vancomycin Susceptibility in Methicillin-Susceptible but Not Methicillin-Resistant Staphylococcus aureus Bacteremia.
- Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy.
- Reply to maiwald et Al and riccio et Al.
- Effectiveness of an information technology intervention to improve prophylactic antibacterial use in the postoperative period.
- Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection.
- Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.
- Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: potential impact of control group selection on characterizing the asso...
- The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.
- Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza.
- Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
- Limitations in using aspiration pneumonia as a quality measure.
- Stockpiling drugs for an avian influenza outbreak: examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide p...
- Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collecte...
- Risk factors for fluconazole-resistant Candida glabrata bloodstream infections.
- Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.
- Effect of accessibility of influenza vaccination on the rate of childcare staff vaccination.
- Treatment and outcomes for patients with bacteremic pneumococcal pneumonia.
- Contact isolation for infection control in hospitalized patients: is patient satisfaction affected?
- Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline.
- Patient attitudes regarding participation in studies of antimicrobial resistance.
- Effect of communication errors during calls to an antimicrobial stewardship program.
- Impact of automatic orders to discontinue vancomycin therapy on vancomycin use in an antimicrobial stewardship program.
- Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa.
- Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of "stealth dosing".
- Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently d...
- Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.
- Macrolide resistance in adults with bacteremic pneumococcal pneumonia.
- Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based sur...
- Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy.
- Inaccurate communications in telephone calls to an antimicrobial stewardship program.
- An uncommon presentation of an uncommon disease: leprosy in a heart transplant recipient.
- Reemergence of gram-negative health care-associated bloodstream infections.
- Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact.
- Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram.
- Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobi...
- Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial t...
- Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
- Strategies for use of a limited influenza vaccine supply.
- High rate of coadministration of di- or tri-valent cation-containing compounds with oral fluoroquinolones: risk factors and potential implications.
- Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit.
- Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidem...
- Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: impact of prior fluoroquinolone use?
- Hospital-reported pneumococcal susceptibility to penicillin.
- Risk factors for postcraniotomy surgical site infection after 1,3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement.
- Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use.
- Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancom...
- Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.
- Trends in antimicrobial susceptibility patterns among inpatient enterococcal isolates (1990 to 1999): implications for therapeutic options.
- Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions o...
- Recognition and management of anthrax.
- Epidemiology and clinical manifestations of human immunodeficiency virus infection.
- Doctors choosing not to be vaccinated is choosing to do harm.
- Costs of false-positive cultures from central catheters.
- Septicemia due to coagulase-negative Staphylococcus in a community hospital.
- Moving toward elimination of healthcare-associated infections: a call to action.
- Ciprofloxacin versus tobramycin for neutropenic fevers.
- Triple-lumen peripherally inserted central catheter in patients in the critical care unit: prospective evaluation.
- Antimicrobial stewardship.
- Expanding roles of healthcare epidemiology and infection control in spite of limited resources and compensation.
- Genetic variants and susceptibility to neurological complications following West Nile virus infection.
- Vancomycin-resistant enterococci: an emerging pathogen in immunosuppressed transplant recipients.
- Evaluation of mannitol salt agar, CHROMagar Staph aureus and CHROMagar MRSA for detection of meticillin-resistant Staphylococcus aureus from nasal swab specimens.
- Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
- Impact of a hospital-based antimicrobial management program on clinical and economic outcomes.
- Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
- Wagging the dog: antibiotic use and the emergence of resistance.
- Control of outbreaks due to organisms producing extended-spectrum beta-lactamases.
- Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus.
- Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital.
- Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
- Acalculous candidal cholecystitis: a previously unrecognized complication after cardiac transplantation.
- The role of herpes simplex virus glycoproteins in immune evasion.
- Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome.
- Recurrent catheter-related Rhodotorula rubra infection.
- Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates.
- Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults.
- Coadministration of oral levofloxacin with agents that impair its absorption: potential impact on emergence of resistance.
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobi...
- Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults.
- Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients.
- Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections.
- SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus.
Schools
Temple University
Temple University Hospital
University Of Pa Health System
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- HealthPartners
- Direct Access
- Horizon Blue Cross Blue Shield HMO
- Horizon Blue Cross Blue Shield POS
- Horizon Blue Cross Blue Shield PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicare MCR
- MultiPlan PPO
- Freedom Plan
- QualCare HMO
- QualCare PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- Regional Top Doctor
- Super Doctor
Education
-
University of Pennsylvania Health System -
Temple University Hospital -
Temple University School of Medicine
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1902838378 | |
| NPPES Provider LastName | FISHMAN | |
| NPPES Provider FirstName | NEIL | |
| NPPES Provider ZIPCode | 191044206 | |
| NPPES Provider State | PA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 58.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902838378 |
| Last Name Of The Provider | FISHMAN |
| First Name Of The Provider | NEIL |
| View All |
Similar Doctors
|
Dr. Eric M. Sachinwalla, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heather E. Clauss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randi S. Silbovsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rituparna Das, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerie C. Cluzet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ian A. Frank Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Pegues, MD
This Doctor is OpenDoctor Recommended.
|